Matthew Cheng

Company: Kanvas Biosciences

Job title: CEO

Seminars:

Preclinical Development of KAN-001: Using Kanvas’ In-House Spatial Host-Microbiome Platform to Inform & Accelerate LBP Development 11:30 am

KAN-001 is a complex LBP consortia candidate derived from a single cancer patient who had a complete response to ICI therapy The patient’s stool, through FMT, has converted multiple ICI-refractory patients to responders Kanvas’ spatial biology platform was used to accelerate strain isolation, visually measure engraftment and inform consortia member selection via microbe-microbe and host-microbe…Read more

day: Conference Day Two